APA (7th ed.) Citation

S, M., G, S., M, P., A, D., M, D., N, L., . . . E, B. (2023). Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: Considerations, requirements, and opportunities. The Lancet. Global health, 11(1), e145. https://doi.org/10.1016/S2214-109X(22)00460-0

Chicago Style (17th ed.) Citation

S, Morin, et al. "Expanding Access to Biotherapeutics in Low-income and Middle-income Countries Through Public Health Non-exclusive Voluntary Intellectual Property Licensing: Considerations, Requirements, and Opportunities." The Lancet. Global Health 11, no. 1 (2023): e145. https://doi.org/10.1016/S2214-109X(22)00460-0.

MLA (9th ed.) Citation

S, Morin, et al. "Expanding Access to Biotherapeutics in Low-income and Middle-income Countries Through Public Health Non-exclusive Voluntary Intellectual Property Licensing: Considerations, Requirements, and Opportunities." The Lancet. Global Health, vol. 11, no. 1, 2023, p. e145, https://doi.org/10.1016/S2214-109X(22)00460-0.